Ozempic May Be Reducing Violent Crime in America and a New Peer-Reviewed Study Has the Data to Prove It

Ozempic is finest identified for shrinking waistlines. It might even be shrinking the probability that somebody acts on a violent impulse.

A Rutgers College examine printed June 17, 2026 within the journal Criminology — the flagship peer-reviewed journal of the American Society of Criminology — has discovered that GLP-1 receptor agonist drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are related to a considerably weaker hyperlink between impulsivity, alcohol use, and violent conduct. The examine was highlighted June 23, 2026 on Medscape in a report on what GLP-1s are educating science about compulsive conduct — underscoring that this discovering is now being taken critically in medical medication, not simply criminology.

The analysis was led by Daniel C. Semenza, PhD, director of analysis on the New Jersey Gun Violence Analysis Heart and affiliate professor at Rutgers Faculty of Public Well being, and co-authored by Christopher Thomas, assistant professor at Rutgers College-Camden. The staff analyzed information from a 2025 nationally consultant survey of seven,521 U.S. adults, focusing particularly on the 821 people who had ever used a GLP-1 remedy, together with 597 who had been at the moment taking one. Violent conduct was measured utilizing a validated self-reported scale masking assault, armed theft, and combating.

The discovering was hanging. Amongst present GLP-1 customers, the well-established hyperlink between impulsivity and violent conduct was roughly 62% weaker than amongst former customers. The connection between alcohol use and violent conduct was roughly 52% weaker amongst present customers. Each associations remained statistically important after controlling for demographic and well being variables.

What the Numbers Present — and What the Researchers Say They Can not Declare

The discovering calls for each critical consideration and critical caveats — and the researchers are express about each.

“Our findings are per these drugs working like cognitive behavioral remedy, weakening the trail from impulse to motion somewhat than eliminating impulsivity itself,” stated Christopher Thomas. The analogy is exact: cognitive behavioral remedy works not by eliminating impulsive ideas however by inserting a pause between impulse and motion. If GLP-1s are doing one thing related by means of neurochemical pathways — performing on reward processing, craving suppression, and dopaminergic methods within the mind — the end result could also be a chemical equal of that skilled pause.

Semenza emphasised that the examine “was fairly shocked with how sturdy the impulsivity discovering was specifically,” however was equally direct about limitations: the examine is observational and cross-sectional. It can’t set up trigger and impact. The pattern of GLP-1 customers was comparatively small at 821. The information is self-reported. And the examine was not designed to establish the organic mechanisms driving the affiliation. “We won’t say with certainty why these associations emerged on this paper,” Semenza informed Healthline.

The researchers additionally cautioned in opposition to concluding that any particular GLP-1 drug is “an anti-crime drug.” As co-author Christopher Thomas informed Vice: “It would not eradicate impulsivity; it simply weakens the connection between impulsivity and motion. You may nonetheless really feel the necessity to do one thing violent; you simply will not give in to it.”

The Science Behind Why This Makes Organic Sense

GLP-1 receptors are usually not solely discovered within the pancreas and intestine. Rising analysis has established that GLP-1 receptors are distributed all through the central nervous system, together with in areas concerned in reward processing, impulsivity, and decision-making, together with the nucleus accumbens, the prefrontal cortex, and the dopamine system broadly. The identical neural circuitry that drives compulsive consuming additionally governs responses to alcohol, different addictive stimuli, and the form of emotional reactivity that may escalate to bodily aggression.

GLP-1 drugs have already been proven in prior peer-reviewed analysis to cut back alcohol cravings, playing urges, and self-reported “meals noise” — the fixed psychological preoccupation with meals that drives compulsive consuming. If the mechanism is a common dampening of reward-seeking and impulse-to-action pathways somewhat than a particular food-related impact, the Rutgers findings are biologically coherent. “Rising analysis means that GLP-1 drugs could affect issues like reward processing and impulse management,” Semenza informed Healthline. “One potential idea right here is that there’s something occurring within the mind by means of these medicine that’s quieting down that noise and permitting form of extra calmness and a extra measured response to issues.”

The examine calls explicitly for future longitudinal and experimental analysis to find out whether or not GLP-1 drugs actually decrease violence threat and to establish the organic mechanisms concerned. Each researchers framed the present paper as a primary step somewhat than a definitive reply — a discovering important sufficient to warrant rigorous follow-up, to not assist coverage modifications with out a lot stronger causal proof.

Steadily Requested Questions

What did the Rutgers GLP-1 violence examine discover?

A Rutgers examine printed June 17 in Criminology discovered that amongst present GLP-1 customers, the hyperlink between impulsivity and violent conduct was roughly 62% weaker than amongst former customers, and the hyperlink between alcohol use and violence was 52% weaker. The examine analyzed information from 821 GLP-1 customers inside a nationally consultant survey of seven,521 adults.

Does this imply Ozempic prevents violent crime?

No. The examine authors had been express that the analysis is observational and cross-sectional, which means it could actually establish associations however can’t show causation. The drug is just not known as an anti-crime drug and shouldn’t be framed as one. Additional longitudinal and experimental research are required.

Why may GLP-1 medicine have an effect on impulsive or violent conduct?

GLP-1 receptors are distributed all through the mind in areas governing reward processing, craving, and impulse management — not simply within the pancreas and intestine. Prior analysis has proven GLP-1 medicine scale back alcohol cravings and compulsive behaviors, suggesting the mechanism could also be a common dampening of impulse-to-action pathways somewhat than a food-specific impact.

Who led this analysis?

The examine was led by Daniel C. Semenza, PhD, director of analysis on the New Jersey Gun Violence Analysis Heart and affiliate professor at Rutgers Faculty of Public Well being, and co-authored by Christopher Thomas, assistant professor at Rutgers College-Camden.

What ought to folks at the moment taking GLP-1 medicine learn about this discovering?

The examine is preliminary. GLP-1 drugs are prescribed for kind 2 diabetes and weight problems administration — not for behavioral or psychiatric circumstances. Anybody taking these drugs for authorized indications mustn’t change their use based mostly on this examine. The discovering warrants additional medical investigation.